ARTHEx Biotech’s ATX-01 is an anti-miRNA oligonucleotide that inhibits miR-23b, thereby restoring MBNL1 protein production and normalizing splicing activity in DM1 [146]. The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.